European vs. Egyptian HCV-4 Patients with Elevated Baseline HCV RNA, Treated with PEG-IFN-α2a and Ribavirin: The Role of Rapid and Early Virologic Response

authors:

avatar Dimitrios Dimitroulopoulos 1 , * , avatar Ioannis Elefsiniotis 2 , avatar Christos Pavlidis 3 , avatar Dimitrios Xinopoulos 1 , avatar Klisthenis Tsamakidis 1 , avatar Stamatina Patsavela 1 , avatar Dimitrios Kypreos 1 , avatar Ageliki Ferderigou 4 , avatar Dimitrios Korkolis 5 , avatar Sotirios Koutsounas 6 , avatar Georgios Saroglou 7 , avatar Emmanouil Paraskevas 8

Department of Gastroenterology, Agios Savvas Hospital, Athens, Greece
Department of Internal Medicine, Helena Venizelou Hospital–University of Athens, Athens, Greece
Reference Center for Viral Hepatitis,IKA, Athens, Athens, Greece
Department of Biochemistry, Agios Savvas Hospital, Athens, Greece
First Surgical Department, Agios Savvas Hospital, Athens, Greece
Reference Center for Viral Hepatitis, IKA, Athens, Greece
Department of Internal Medicine, Helena Venizelou Hospital – University of Athens, Athens, Greece
Department of Gastroenterology,Agios SavvasHospital, Athens, Greece

how to cite: Dimitroulopoulos D, Elefsiniotis I, Pavlidis C, Xinopoulos D, Tsamakidis K, et al. European vs. Egyptian HCV-4 Patients with Elevated Baseline HCV RNA, Treated with PEG-IFN-α2a and Ribavirin: The Role of Rapid and Early Virologic Response. Hepat Mon. 2010;10(3):e92981.

Abstract

Fulltext

References

  • 1.

    The references are available in the PDF file.

© 2010, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.